Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip ...
Zimmer Biomet earns FDA clearance for the G7 Acetabular System, enabling U.S. commercialization of this advanced hip implant.
BOCA RATON, Fla.--(BUSINESS WIRE)--Medical device manufacturer Zimmer Inc. has been ordered to pay more than $2 million to a New Mexico man for a defective Zimmer hip implant with an “unreasonably ...
PUNE, India, May 7, 2017 /PRNewswire-iReach/ -- Hip Replacement Implants Market: Overview The global market overview for hip replacement implants looks promising considering advances in ...
iTaperloc ® Complete and iG7 ™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77. The orthopedic giant reported sales of $1.91 ...
Please provide your email address to receive an email when new articles are posted on . Zimmer Biomet Holdings Inc. has announced the acquisition of Ossis. Ossis is a medical device company that ...
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M. Murthi Appointed Chief Medical Advisor, Shoulder, Sports, Extremities, and Trauma ...
WARSAW, Ind., Sept. 1, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced an exclusive, multi-year co-marketing agreement with ...
Zimmer Biomet Holdings, Inc. ZBH recently inked an exclusive, multi-year co-marketing agreement with Surgical Planning Associates, Inc. to commercialize the FDA-approved HipInsight mixed reality ...
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition of Monogram Technologies WARSAW, Ind., Oct. 21, ...